skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

Chalasani, Naga ; Abdelmalek, Manal F. ; Garcia-Tsao, Guadalupe ; Vuppalanchi, Raj ; Alkhouri, Naim ; Rinella, Mary ; Noureddin, Mazen ; Pyko, Maxmillan ; Shiffman, Mitchell ; Sanyal, Arun ; Allgood, Adam ; Shlevin, Harold ; Horton, Rex ; Zomer, Eliezer ; Irish, William ; Goodman, Zachary ; Harrison, Stephen A. ; Traber, Peter G. ; Abdelmalek, Manal ; Balart, Luis ; Borg, Brian ; Chalasani, Naga ; Charlton, Michael ; Conjeevaram, Hari ; Fuchs, Michael ; Ghalib, Reem ; Gholam, Pierre ; Halegoua-De Marzio, Dina ; Harrison, Stephen ; Jue, Christopher ; Kemmer, Nyingi ; Kowdley, Kris ; Lai, Michelle ; Lawitz, Eric ; Loomba, Rohit ; Noureddin, Mazen ; Paredes, Angelo ; Rinella, Mary ; Rockey, Don ; Rodriguez, Miguel ; Rubin, Raymond ; Ryan, Michael ; Sanyal, Arun ; Scanga, Andrew ; Sepe, Thomas ; Shiffman, Mitchell ; Tetri, Brent ; Thuluvath, Paul ; Torres, Dawn ; Vierling, John ; Wattacheril, Julia ; Weiland, Amanda ; Zogg, Donald

Gastroenterology (New York, N.Y. 1943), 2020-04, Vol.158 (5), p.1334-1345.e5 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

Villanueva, Càndid ; Albillos, Agustín ; Genescà, Joan ; Garcia-Pagan, Joan C ; Calleja, José L ; Aracil, Carles ; Bañares, Rafael ; Morillas, Rosa M ; Poca, María ; Peñas, Beatriz ; Augustin, Salvador ; Abraldes, Juan G ; Alvarado, Edilmar ; Torres, Ferran ; Bosch, Jaume

The Lancet (British edition), 2019-04, Vol.393 (10181), p.1597-1608 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy
Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy

Mandorfer, Mattias ; Kozbial, Karin ; Schwabl, Philipp ; Chromy, David ; Semmler, Georg ; Stättermayer, Albert F. ; Pinter, Matthias ; Hernández‐Gea, Virginia ; Fritzer‐Szekeres, Monika ; Steindl‐Munda, Petra ; Trauner, Michael ; Peck‐Radosavljevic, Markus ; García‐Pagán, Juan C. ; Ferenci, Peter ; Reiberger, Thomas

Hepatology (Baltimore, Md.), 2020-03, Vol.71 (3), p.1023-1036 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
4
Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis
Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis

Villanueva, Càndid ; Torres, Ferran ; Sarin, Shiv Kumar ; Shah, Hasnain Ali ; Tripathi, Dhiraj ; Brujats, Anna ; Rodrigues, Susana G. ; Bhardwaj, Ankit ; Azam, Zahid ; Hayes, Peter C. ; Jindal, Ankur ; Abid, Shahab ; Alvarado, Edilmar ; Bosch, Jaume

Journal of hepatology, 2022-10, Vol.77 (4), p.1014-1025 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
5
Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments
Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments

Bosch, Jaume ; Groszmann, Roberto J ; Shah, Vijay H

Journal of hepatology, 2015-04, Vol.62 (1), p.S121-S130 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
6
Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial
Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial

Sitbon, Olivier ; Bosch, Jaume ; Cottreel, Emmanuelle ; Csonka, Denes ; de Groote, Pascal ; Hoeper, Marius M ; Kim, Nick H ; Martin, Nicolas ; Savale, Laurent ; Krowka, Michael

The lancet respiratory medicine, 2019-07, Vol.7 (7), p.594-604 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis
Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis

Oró, Denise ; Yudina, Tetyana ; Fernández-Varo, Guillermo ; Casals, Eudald ; Reichenbach, Vedrana ; Casals, Gregori ; González de la Presa, Bernardino ; Sandalinas, Silvia ; Carvajal, Silvia ; Puntes, Victor ; Jiménez, Wladimiro

Journal of hepatology, 2016-03, Vol.64 (3), p.691-698 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
8
Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease
Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease

Boyer-Diaz, Zoe ; Aristu-Zabalza, Peio ; Andrés-Rozas, María ; Robert, Claude ; Ortega-Ribera, Martí ; Fernández-Iglesias, Anabel ; Broqua, Pierre ; Junien, Jean-Louis ; Wettstein, Guillaume ; Bosch, Jaime ; Gracia-Sancho, Jordi

Journal of hepatology, 2021-05, Vol.74 (5), p.1188-1199 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
9
Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
Material Type:
Artigo 		Adicionar ao Meu Espaço

Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats

Verbeke, Len ; Farre, Ricard ; Trebicka, Jonel ; Komuta, Mina ; Roskams, Tania ; Klein, Sabine ; Elst, Ingrid Vander ; Windmolders, Petra ; Vanuytsel, Tim ; Nevens, Frederik ; Laleman, Wim

Hepatology (Baltimore, Md.), 2014-06, Vol.59 (6), p.2286-2298 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
10
Cirrhotic portal hypertension: From pathophysiology to novel therapeutics
Cirrhotic portal hypertension: From pathophysiology to novel therapeutics
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cirrhotic portal hypertension: From pathophysiology to novel therapeutics

Gunarathne, Lakmie S ; Rajapaksha, Harinda ; Shackel, Nicholas ; Angus, Peter W ; Herath, Chandana B

World journal of gastroenterology : WJG, 2020-10, Vol.26 (40), p.6111-6140

United States: Baishideng Publishing Group Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (754)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (817)
  2. magazinearticle  (2)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1983  (26)
  2. 1983Até1992  (106)
  3. 1993Até2002  (170)
  4. 2003Até2013  (310)
  5. Após 2013  (208)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (781)
  2. Japonês  (88)
  3. Espanhol  (16)
  4. Alemão  (11)
  5. Francês  (6)
  6. Português  (4)
  7. Dinamarquês  (2)
  8. Russo  (1)
  9. Serbian  (1)
  10. Coreano  (1)
  11. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.